Genpact Limited (G) Key Metrics
G valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $6.23B
- Enterprise value
- $6.59B
- P/E (TTM)
- 11.1 10-yr median 21.5
- Forward P/E
- 18.3
- PEG ratio
- 1.16
- Price / sales
- 1.2 10-yr median 2.0
- Price / book
- 2.2 10-yr median 4.2
- EV / EBITDA
- 7.0 10-yr median 13.9
- Dividend yield
- 2.01% $0.75 a year
- Beta
- 0.58
G key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsG valuation Price multiples at each fiscal year-end price.
G returns How much profit the business earns on the capital it uses.
G per-share figures Results divided by the shares outstanding at year-end.
G financial health Debt, liquidity and how easily interest is covered.
G efficiency & capital use Working capital cycle and where the cash goes.
G valuation history
G returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
G debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
G cash returned to shareholders
G price vs earnings per share
G key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $8.26B | $7.75B | $6.43B | $8.71B | $10.24B | $8.10B | $8.23B | $5.24B | $6.25B | $5.11B |
| Enterprise value | $8.82B | $8.52B | $7.35B | $9.76B | $11.34B | $9.40B | $9.60B | $6.17B | $6.97B | $5.59B |
| P/E ratio | 15.0 | 15.1 | 10.2 | 24.7 | 27.7 | 26.3 | 27.0 | 18.6 | 24.0 | 19.1 |
| Price / sales | 1.6 | 1.6 | 1.4 | 2.0 | 2.5 | 2.2 | 2.3 | 1.7 | 2.3 | 2.0 |
| Price / book | 3.2 | 3.2 | 2.9 | 4.8 | 5.4 | 4.4 | 4.9 | 3.7 | 4.4 | 4.0 |
| Price / free cash flow | 11.2 | 14.6 | 14.9 | 22.4 | 16.1 | 16.1 | 25.8 | 29.2 | 21.9 | 19.9 |
| Price / operating cash flow | 10.2 | 12.6 | 13.1 | 19.6 | 14.8 | 13.9 | 19.2 | 15.4 | 17.4 | 14.8 |
| EV / sales | 1.7 | 1.8 | 1.6 | 2.2 | 2.8 | 2.5 | 2.7 | 2.1 | 2.5 | 2.2 |
| EV / EBITDA | 10.1 | 10.3 | 11.6 | 15.0 | 16.0 | 15.3 | 16.6 | 12.0 | 15.3 | 12.9 |
| EV / free cash flow | 12.0 | 16.1 | 17.0 | 25.1 | 17.8 | 18.7 | 30.1 | 34.5 | 24.4 | 21.7 |
| Earnings yield | 6.7% | 6.6% | 9.8% | 4.1% | 3.6% | 3.8% | 3.7% | 5.4% | 4.2% | 5.2% |
| Free cash flow yield | 8.9% | 6.8% | 6.7% | 4.5% | 6.2% | 6.2% | 3.9% | 3.4% | 4.6% | 5.0% |
| Dividend yield | 1.4% | 1.4% | 1.6% | 1.1% | 0.8% | 0.9% | 0.8% | 1.1% | 0.7% | 3.9% |
| Shareholder yield (dividends + buybacks) | 4.9% | 4.7% | 5.1% | 3.5% | 3.7% | 2.6% | 1.2% | 4.0% | 4.3% | 10.6% |
| Share price at fiscal year-end | $46.78 | $42.95 | $34.71 | $46.32 | $53.08 | $41.36 | $42.17 | $26.99 | $31.74 | $24.34 |
| Per share | ||||||||||
| Revenue per share | $28.76 | $26.42 | $24.18 | $23.24 | $20.84 | $18.95 | $18.04 | $15.47 | $13.89 | $12.23 |
| Earnings per share | $3.13 | $2.85 | $3.41 | $1.88 | $1.91 | $1.57 | $1.56 | $1.45 | $1.32 | $1.27 |
| Operating cash flow per share | $4.60 | $3.41 | $2.65 | $2.36 | $3.60 | $2.98 | $2.19 | $1.75 | $1.82 | $1.65 |
| Free cash flow per share | $4.16 | $2.94 | $2.33 | $2.07 | $3.30 | $2.57 | $1.64 | $0.92 | $1.45 | $1.22 |
| Cash per share | $6.81 | $3.72 | $3.15 | $3.44 | $4.66 | $3.48 | $2.39 | $1.90 | $2.56 | $2.01 |
| Book value per share | $14.43 | $13.24 | $12.14 | $9.71 | $9.83 | $9.37 | $8.66 | $7.24 | $7.23 | $6.12 |
| Tangible book value per share | $3.97 | $3.84 | $2.76 | $0.28 | −$0.02 | −$0.50 | −$0.60 | −$0.86 | −$0.23 | $0.69 |
| Dividends per share | $0.67 | $0.60 | $0.54 | $0.49 | $0.42 | $0.38 | $0.33 | $0.29 | $0.24 | $0.95 |
| Capex per share | $0.44 | $0.47 | $0.32 | $0.29 | $0.30 | $0.41 | $0.56 | $0.83 | $0.37 | $0.42 |
| Debt per share | $9.99 | $8.01 | $8.12 | $9.03 | $10.37 | $10.14 | $9.39 | $6.72 | $6.17 | $4.27 |
| Shares outstanding | 176.6M | 180.4M | 185.1M | 188.1M | 193.0M | 195.8M | 195.2M | 194.0M | 197.0M | 210.1M |
| Change in shares outstanding | −2.1% | −2.5% | −1.6% | −2.5% | −1.4% | +0.3% | +0.6% | −1.6% | −6.2% | −4.1% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 22.4% | 22.2% | 31.0% | 19.0% | 19.8% | 17.5% | 19.7% | 19.9% | 19.2% | 20.7% |
| Return on invested capital (ROIC) | 18.3% | 16.8% | 20.9% | 13.0% | 12.7% | 10.9% | 12.1% | 12.1% | 13.8% | 16.2% |
| Return on assets (ROA) | 10.2% | 10.5% | 13.4% | 7.4% | 7.5% | 6.6% | 7.6% | 8.1% | 8.2% | 9.4% |
| Return on tangible assets | 13.8% | 15.6% | 20.6% | 12.6% | 12.0% | 10.5% | 11.5% | 14.4% | 13.2% | 15.3% |
| Free cash flow margin | 14.5% | 11.1% | 9.7% | 8.9% | 15.8% | 13.6% | 9.1% | 6.0% | 10.4% | 10.0% |
| Income quality (OCF / net income) | 1.47 | 1.20 | 0.78 | 1.26 | 1.88 | 1.90 | 1.40 | 1.21 | 1.38 | 1.29 |
| Financial health | ||||||||||
| Total debt | $1.76B | $1.45B | $1.50B | $1.70B | $2.00B | $1.99B | $1.83B | $1.30B | $1.22B | $897.3M |
| Cash & short-term investments | $1.20B | $671.6M | $583.7M | $646.8M | $899.5M | $680.4M | $467.1M | $368.4M | $504.5M | $422.6M |
| Net debt | $560.7M | $773.5M | $919.3M | $1.05B | $1.10B | $1.31B | $1.37B | $935.7M | $711.4M | $474.7M |
| Debt / equity | 0.69 | 0.60 | 0.67 | 0.93 | 1.05 | 1.08 | 1.09 | 0.93 | 0.85 | 0.70 |
| Debt / assets | 0.30 | 0.29 | 0.31 | 0.37 | 0.40 | 0.41 | 0.41 | 0.37 | 0.35 | 0.31 |
| Net debt / EBITDA | 0.64 | 0.94 | 1.46 | 1.61 | 1.55 | 2.12 | 2.36 | 1.82 | 1.56 | 1.09 |
| Current ratio | 1.66 | 2.16 | 1.44 | 1.61 | 1.47 | 1.45 | 1.70 | 1.39 | 1.71 | 1.68 |
| Quick ratio | 1.66 | 2.16 | 1.43 | 1.61 | 1.39 | 1.33 | 1.57 | 1.23 | 1.48 | 1.44 |
| Interest coverage | 10.3 | 8.8 | 13.2 | 8.6 | 8.7 | 7.8 | 8.5 | 7.2 | 8.3 | 14.6 |
| Working capital | $1.05B | $1.12B | $573.6M | $676.2M | $612.8M | $546.2M | $641.5M | $378.7M | $595.1M | $495.7M |
| Invested capital | $3.11B | $3.16B | $3.17B | $2.88B | $3.00B | $3.14B | $3.06B | $2.34B | $2.14B | $1.76B |
| Tangible asset value | $701.2M | $692.9M | $511.6M | $52.2M | −$3.5M | −$98.2M | −$116.2M | −$166.7M | −$44.7M | $145.2M |
| Net current asset value | −$637.5M | −$517.4M | −$665.8M | −$983.2M | −$1.16B | −$1.29B | −$1.21B | −$770.2M | −$591.7M | −$372.2M |
| Graham number | $31.87 | $29.13 | $30.52 | $20.26 | $20.58 | $18.22 | $17.44 | $15.37 | $14.67 | $13.24 |
| Graham net-net per share | −$6.40 | −$5.56 | −$6.04 | −$7.24 | −$7.54 | −$8.26 | −$7.88 | −$5.59 | −$4.60 | −$2.99 |
| Capital allocation | ||||||||||
| Dividends paid | $117.7M | $108.5M | $100.0M | $91.8M | $80.5M | $74.2M | $64.7M | $57.1M | $46.7M | $199.2M |
| Share buybacks (net) | $283.0M | $252.7M | $225.5M | $214.1M | $298.2M | $137.1M | $30.0M | $154.2M | $219.8M | $345.2M |
| Dividend payout ratio | 21.3% | 21.1% | 15.8% | 26.0% | 21.8% | 24.1% | 21.2% | 20.3% | 17.9% | 74.5% |
| Dividends + buybacks / free cash flow | 54.6% | 68.1% | 75.3% | 78.6% | 59.4% | 41.9% | 29.7% | 118.0% | 93.4% | 211.8% |
| Capex / revenue | 1.5% | 1.8% | 1.3% | 1.2% | 1.4% | 2.2% | 3.1% | 5.3% | 2.7% | 3.5% |
| Capex / operating cash flow | 9.6% | 13.8% | 12.0% | 12.3% | 8.2% | 13.8% | 25.4% | 47.2% | 20.5% | 25.7% |
| Capex / depreciation | 0.82 | 1.22 | 0.57 | 0.42 | 0.34 | 0.50 | 0.84 | 1.55 | 0.78 | 1.09 |
| Stock-based compensation / revenue | 1.8% | 1.4% | 2.0% | 1.8% | 2.0% | 2.0% | 2.4% | 1.6% | 1.3% | 1.0% |
| R&D / revenue | — | — | — | 0.6% | 0.0% | 0.1% | 0.1% | 0.1% | — | — |
| SG&A / revenue | 20.6% | 20.3% | 20.4% | 21.5% | 19.5% | 21.3% | 22.6% | 23.1% | 25.2% | 25.4% |
| Efficiency | ||||||||||
| Days sales outstanding | 90.2 | 90.5 | 87.2 | 79.4 | 81.1 | 89.7 | 89.7 | 90.6 | 87.2 | 85.6 |
| Days of inventory on hand | — | — | 0.6 | 6.7 | 17.9 | 20.5 | 21.6 | 32.4 | 39.5 | 36.0 |
| Days payables outstanding | 3.6 | 3.8 | 4.0 | 3.9 | 2.7 | 2.7 | 5.1 | 5.5 | 2.7 | 2.3 |
| Cash conversion cycle (days) | 86.6 | 86.7 | 83.8 | 82.2 | 96.2 | 107.5 | 106.1 | 117.6 | 124.0 | 119.2 |
| Receivables turnover | 4.05 | 4.03 | 4.18 | 4.59 | 4.50 | 4.07 | 4.07 | 4.03 | 4.18 | 4.27 |
| Payables turnover | 102.28 | 95.85 | 91.47 | 93.26 | 133.20 | 134.75 | 71.08 | 66.69 | 135.50 | 156.58 |
| Inventory turnover | — | — | 612.29 | 54.65 | 20.41 | 17.83 | 16.91 | 11.25 | 9.24 | 10.14 |
| Asset turnover | 0.94 | 0.97 | 0.95 | 0.91 | 0.82 | 0.80 | 0.88 | 0.86 | 0.86 | 0.91 |
| Average receivables | $1.26B | $1.18B | $1.07B | $951.3M | $893.2M | $911.7M | $865.0M | $744.9M | $654.2M | $602.7M |
| Average payables | $32.0M | $32.1M | $31.8M | $30.4M | $19.4M | $17.9M | $32.3M | $28.8M | $12.4M | $9.9M |
| Average inventory | — | — | $4.7M | $51.9M | $126.9M | $135.6M | $135.7M | $170.8M | $182.0M | $153.3M |
| Intangibles / total assets | 31.6% | 34.0% | 36.1% | 38.7% | 38.2% | 39.7% | 40.5% | 44.5% | 42.6% | 39.6% |
Computed from G's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
G valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Genpact traded at 15.0 times earnings, against a 10-year median of 21.5. Based on the latest twelve months, the trailing P/E is 11.1 and the forward P/E is 18.3. Genpact earned a return on equity of 22.4% and a return on invested capital of 18.3% in fiscal 2025. It ended the year with $1.8 billion of debt and $1.2 billion in cash and short-term investments, net debt of $560.7 million. It returned $400.8 million to shareholders: $117.7 million in dividends and $283.0 million in share buybacks, 55% of free cash flow. The share count fell 15.9% from 210.1M to 176.6M over 9 years.
See the G income statement, the G chart for price history, or the G stock overview for the latest quote and news.
G key metrics FAQ
What is Genpact's P/E ratio?
Genpact's trailing P/E ratio is 11.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 18.3. At the end of fiscal 2025 it was 15.0, compared with a 10-year median of 21.5.
What is Genpact's EV/EBITDA?
Genpact's enterprise value was 10.1 times EBITDA at the end of fiscal 2025 (enterprise value $8.8 billion, EBITDA $874.7 million); the current EV/EBITDA is 7.0.
What is Genpact's return on equity?
Genpact's return on equity (ROE) was 22.4% in fiscal 2025: net income of $552.5 million on average shareholders' equity of $2.5 billion.
What is Genpact's ROIC?
Genpact's return on invested capital was 18.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Genpact have?
Genpact had total debt of $1.8 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.69 and $560.7 million of net debt (0.64 times EBITDA).
What is Genpact's dividend yield?
Genpact's forward dividend yield is 2.01%. Genpact paid $117.7 million in dividends in fiscal 2025 ($0.67 per share), a payout ratio of 21.3%.
Does Genpact buy back its shares?
Yes. Genpact spent $283.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −2.1% over the year, to 176.6M..
What is Genpact's free cash flow yield?
Genpact generated $734.7 million of free cash flow in fiscal 2025, a free cash flow yield of 8.9% on its market value at year-end ($8.3 billion).
What is Genpact's current ratio?
Genpact's current ratio was 1.66 at the end of fiscal 2025: current assets were 1.66 times current liabilities.